Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Fei Cheng

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Leukemia Research|February 29, 2020
Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemiaLu Bai, Yi-Fei Cheng, Ai-Dong Lu, et al.
Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.
Frontiers in Immunology|January 24, 2022
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionGuan-Hua Hu, Yi-Fei Cheng, Ying-Xi Zuo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy <sup>125</sup>I Seed Enhances Anticancer Efficacy by Rescuing Immune EscapeBin Xu, Ye-Ming Wu, Yi-Fei Cheng, et al.
Cytotherapy|August 31, 2020
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantationYu-Hong Chen, Xian Zhang, Yi-Fei Cheng, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|April 2, 2024
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experienceRui Ma, Dan-Ping Zhu, Xiao-Hui Zhang, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Leukemia Research|February 29, 2020
Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemiaLu Bai, Yi-Fei Cheng, Ai-Dong Lu, et al.
Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.
Frontiers in Immunology|January 24, 2022
Chimeric Antigens Receptor T Cell Therapy Improve the Prognosis of Pediatric Acute Lymphoblastic Leukemia With Persistent/Recurrent Minimal Residual Disease in First Complete RemissionGuan-Hua Hu, Yi-Fei Cheng, Ying-Xi Zuo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2025
A Novel Self-Regulated, Non-Directional Magnetic Thermos-Brachytherapy <sup>125</sup>I Seed Enhances Anticancer Efficacy by Rescuing Immune EscapeBin Xu, Ye-Ming Wu, Yi-Fei Cheng, et al.
Cytotherapy|August 31, 2020
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantationYu-Hong Chen, Xian Zhang, Yi-Fei Cheng, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|April 2, 2024
Salvage haploidentical transplantation for graft failure after first haploidentical allogeneic stem cell transplantation: an updated experienceRui Ma, Dan-Ping Zhu, Xiao-Hui Zhang, et al.
Pageof 9